Drugs / hypertonic saline solution
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02729012 Comparator | Oct 2015 → Jun 2016 | allergic rhinitis | Stefania La Grutta, MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hypertonic saline solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02729012 ↗ |
| Route | Inhaled | “Treatment with nebulized hypertonic saline solution (NACL 3%+NAHCO3)” NCT02729012 ↗ |